Your search returned 2 results.

Results
	1.	IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients. [electronic resource] by Schilling, B Halstead, E S Schuler, P Harasymczuk, M Egan, J E Whiteside, T L Producer: 20130123 In: Cancer immunology, immunotherapy : CII vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells. [electronic resource] by Schuler, P J Saze, Z Hong, C-S Muller, L Gillespie, D G Cheng, D Harasymczuk, M Mandapathil, M Lang, S Jackson, E K Whiteside, T L Producer: 20141010 In: Clinical and experimental immunology vol. 177 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search